CYTO — Cytophage Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- CA$15.42m
- CA$15.63m
Annual cashflow statement for Cytophage Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -3.24 | -3.68 | -4.64 | -7.86 |
| Depreciation | ||||
| Non-Cash Items | 0.054 | 0.45 | 0.832 | 2.69 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.147 | -0.075 | 0.432 | -0.304 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Cash from Operating Activities | -3.03 | -2.94 | -2.86 | -4.77 |
| Capital Expenditures | -0.333 | -0.381 | -0.162 | -1.3 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | — | -2.46 | 7.62 |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -0.333 | -0.381 | -2.62 | 6.32 |
| Financing Cash Flow Items | -0.091 | 0 | 2.45 | -0.029 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 6.58 | 0.728 | 3.26 | -0.06 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 3.22 | -2.6 | -2.21 | 1.49 |